Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.610
-0.310 (-6.30%)
At close: May 8, 2026, 4:00 PM EDT
4.650
+0.040 (0.87%)
After-hours: May 8, 2026, 5:05 PM EDT
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $595.35 million as of May 8, 2026. Its market cap has increased by 21.67% in one year.
Market Cap
595.35M
Enterprise Value
360.60M
1-Year Change
21.67%
Ranking
Category
Stock Price
$4.61
Market Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $595.35M, a decrease of -73.67%. That is a compound annual growth rate of -24.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 595.35M | -7.80% |
| Dec 31, 2025 | 645.72M | -22.76% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
| Jul 23, 2021 | 2.26B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SS Innovations International | 773.77M |
| CeriBell | 764.65M |
| QuidelOrtho | 736.46M |
| BrainsWay | 694.68M |
| NeuroPace | 622.99M |
| Tactile Systems Technology | 578.57M |
| SI-BONE | 542.87M |
| Cerus | 522.96M |